Novo Nordisk cuts Wegovy prices in half for cash-paying consumers

1. Novo Nordisk halves Wegovy price to $499 for uninsured U.S. patients. 2. FDA confirms Wegovy supply shortage resolved, meeting U.S. demand. 3. Increasing competition prompts price cuts across the weight-loss drug market. 4. Novo Nordisk forecasts slower sales growth in 2025 due to competition. 5. Eli Lilly also cuts prices for its weight-loss drug, Zepbound.